Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, especially now that a shiny sun is finally appearing over what has been an especially cloudy Pharmalot campus these past few days. The official mascots are enjoying the change of pace, as well, as they curl up alongside us. All this coziness calls for a cup of stimulation — Cinnamon Coffee Roll is on the menu today, if you care — as we hustle about for interesting items. Speaking of which, here are some tidbits. Have a smashing day and do keep in touch …

The Food and Drug Administration fired back at Amgen over a lawsuit the drug maker filed in which it alleged the agency denied a marketing incentive for studying one of its medicines for children. In a court filing, the FDA argued that Amgen, which was required to run four studies in exchange for pediatric exclusivity, failed to complete a “critical safety study in the youngest, most vulnerable patients.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!